GENEONE LIFE SCIENCE, INC.

Press Releases GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-01 pm EDT			5-day change	1st Jan Change
2,120 ^KRW	+0.95%		+0.95%	-25.35%

May. 16	GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 28	GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Varicella Zoster Infections Pipeline Landscape Analysis of 03+ Companies by DelveInsight \| Leading Companies - Curevo Vaccine, GeneOne Life Science, SK Bioscience, and Others	22-10-04	AQ
GeneOne Life Science : VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies	21-03-17	AQ
GeneOne Life Science : VGXI Wins Best Contract Manufacturing Organization for the 2020 Vaccine Industry Excellence Awards	20-10-02	AQ
Inovio Pharmaceuticals : VGXI Enables Rapid GMP DNA Manufacturing Timeline for Geneos Therapeutics Personalized Cancer Immunotherapy	20-05-20	AQ
Inovio Pharmaceuticals : VGXI Supports Rapid Timeline to Clinical Testing for Coronavirus Vaccine	20-04-07	AQ
GeneOne Life Science : VGXI Recognized as Best CMO Finalist for the 2020 Vaccine Industry Excellence Awards	20-03-05	AQ
GeneOne Life Science : VGXI, Inc. Establishes Pilot mRNA Manufacturing Capabilities	19-12-09	AQ
GeneOne Life Science : VGXI Selects BE&K as Design-Build Partner for New Manufacturing Facility	19-12-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer